Skip to main content
. 2006 Dec 19;109(7):3069–3075. doi: 10.1182/blood-2006-08-043257

Table 1.

Subject characteristics

Characteristics Data
Total, no. 17
No. men/no. women 9/8
Median age, y (range) 68 (49-88)
Rai stage, no.
    0 5
    1 5
    2 3
    3 3
    4 1
Prior therapy, no.
    None 11
    Chlorambucil 2
    Chlorambucil, rituximab 3
    Cyclophosphamide, prednisone, rituximab 1
Median absolute lymphocyte count × 109/L (range) 32.5 (1.8-224.4)
CD38, no. 16
CD38+, no. 1
Interphase cytogenetics, FISH, no.
    del 13q14 3
    del 13q14, +12 1
    del 13q14, ATM 1
    p53 1
    No abnormalities 2
    Not available 9
HHS Vulnerability Disclosure